Low vitamin D levels linked to metabolic syndrome

By Stephen Daniells

- Last updated on GMT

Increasing blood levels of vitamin D are linked to a lower prevalence of the metabolic syndrome, as well as improved ‘good’ cholesterol levels, says a new study.

According to findings published in the Journal of Clinical Lipidology​, the lowest levels of the sunshine vitamin were associated with a 31 per cent prevalence of metabolic syndrome, compared to only 10 per cent for people wit the highest average levels.

The researchers noted that the results do not prove that low vitamin D levels contributes or causes metabolic syndrome, and called for more studies to “assess whether increasing vitamin D intake will improve the metabolic cardiovascular risk factor profile”​.

“Although previous surveys have also reported associations between low 25(OH)D concentration and metabolic syndrome components, to our knowledge, the present investigation is the first to report this finding in a sample with a high prevalence of vitamin D dietary supplement users in which frequencies of vitamin D insufficiency and deficiency were low,”​ wrote the researchers, led by Kevin Maki from Illinois-based Provident Clinical Research

Metabolic syndrome (MetS) is a condition characterised by central obesity, hypertension, and disturbed glucose and insulin metabolism. The syndrome has been linked to increased risks of both type-2 diabetes and cardiovascular disease (CVD).

Study details

The researchers analysed vitamin D levels in the blood of 257 men and women aged over 18. Dietary and supplementary intakes were assessed using a food frequency and dietary supplement questionnaires, said the researchers.

Their results showed that vitamin D blood levels were associated with HDL cholesterol levels.

“The most notable finding from the present study was the strong relationship between serum concentrations of 25(OH)D and HDL-C concentrations,”​ wrote the researchers.

“Each 10 ng/mL increment in 25(OH)D was associated with an increase of 3.8 to 4.2 mg/dL in HDL-C [...] This is of considerable potential importance given that each 1 mg/dL increment in HDL-C is associated with a 4 to 6 per cent reduction in coronary heart disease (CHD) risk.”

They also observed inverse associations between vitamin D levels and triglyceride levels, body mass index, and waist circumference, meaning that higher vitamin D levels were associated with lower values for these measurables.

Explanation

“A potential explanation for our observation of an inverse association between 25(OH)D and indicators of adiposity (waist and body mass index) may be that vitamin D is fat soluble and is therefore easily sequestered in adipose tissue,”​ wrote the researchers.

“Thus, there is a greater storage capacity for vitamin D in overweight and obese individuals, which may result in a reduced circulating concentration of 25(OH)D.

“As a result, in order to maintain a given circulating 25(OH)D concentration, overweight and obese individuals may have to consume higher quantities of vitamin D than would be the case for normal weight populations,”​ they said.

Source: Journal of Clinical Lipidology
Published online ahead of print, doi: 10.1016/j.jacl.2009.07.003
“Serum 25-Hydroxyvitamin D is Independently Associated with High Density Lipoprotein Cholesterol and the Metabolic Syndrome in Men and Women”
Authors: K.C. Maki, M.R. Rubin, L.G. Wong, J.F. McManus, C.D. Jensen, J.W. Marshall, A. Lawless

Related news

Show more

Related products

show more

Resveratrol – Revitalizing Cognitive Function

Resveratrol – Revitalizing Cognitive Function

Evolva | 29-Sep-2017 | Technical / White Paper

Cognitive decline is fast becoming the biggest concern of the 65+ population. A population which is set to reach 1.1 billion by 2030*.  · 80% of 60+ take...

Transparency and Dietary Supplement Quality

Transparency and Dietary Supplement Quality

Gemini Pharmaceuticals | 18-Sep-2017 | Technical / White Paper

A Brand Owner is 100% responsible for the quality of their products - not the Contract Manufacturing Organization (CMO). This is exactly why Gemini Pharmaceuticals developed...

Product Cost Reduction Strategies for the Brand Owner

Product Cost Reduction Strategies for the Brand Owner

Gemini Pharmaceuticals | 11-Sep-2017 | Technical / White Paper

Brand Owners are feeling product price pressure from all corners these days. Consumers are demanding more of the products they buy and want them at a lower...

Related suppliers

Follow us

Products

View more

Webinars